Edward Tam
Impact in
- Hepatology top 1%
- Hepatitis C virus research
- Liver Disease and Transplantation
- Epidemiology top 5%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
Papers in
- Hepatology 22
- Hepatitis C virus research 20
- Liver Diseases and Immunity 2
- Epidemiology 15
- Liver Disease Diagnosis and Treatment 10
- Hepatitis B Virus Studies 9
- Co-authors
- Fred Poordad (2 shared papers)Lois Larsen (2 shared papers)Paul Desmond (1 shared paper)Peter Varunok (1 shared paper)Barry Bernstein (1 shared paper)Rui Tato Marinho (1 shared paper)Marc Bourlière (1 shared paper)Donald M. Jensen (2 shared papers)
- Journals
- Journal of Hepatology (7 papers)Gastroenterology (4 papers)Liver International (2 papers)Journal of Clinical Microbiology (1 paper)Heart Rhythm (1 paper)
- Partner nations
- CanadaUnited StatesHong Kong
In The Last Decade
Edward Tam
31 papers receiving 845 citations
Edward Tam's Hit Papers
Peers
Comparison fields: 5 of 61
- Hepatology 615
- Epidemiology 450
- Infectious Diseases 140
- Dermatology 17
- Cancer Research 26
Countries citing papers authored by Edward Tam
This map shows the geographic impact of Edward Tam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Tam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Tam more than expected).
Fields of papers citing papers by Edward Tam
This network shows the impact of papers produced by Edward Tam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Tam. The network helps show where Edward Tam may publish in the future.
Co-authors
The 25 scholars most cited alongside Edward Tam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin Hit paper breakdown → | 2014 | 396 |
| 2 | 2015 | 110 | |
| 3 | 2018 | 67 | |
| 4 | 2020 | 47 | |
| 5 | 1993 | 34 | |
| 6 | 2017 | 33 | |
| 7 | 2011 | 30 | |
| 8 | 2014 | 20 | |
| 9 | 2021 | 18 | |
| 10 | 2021 | 17 | |
| 11 | 2022 | 16 | |
| 12 | 2020 | 14 | |
| 13 | 2017 | 11 | |
| 14 | 2023 | 8 | |
| 15 | 2016 | 5 | |
| 16 | A novel genetic pathway involving L76V and M46I leading to lopinavir/r resistance | 2007 | 5 |
| 17 | 2014 | 5 | |
| 18 | 2022 | 4 | |
| 19 | 2022 | 3 | |
| 20 | 2022 | 2 |
About Edward Tam
Edward Tam is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Molecular Biology and Cancer Research, having authored 36 papers that have together received 860 indexed citations. Recurring topics across this work include Hepatitis C virus research (20 papers), Liver Disease Diagnosis and Treatment (10 papers), Hepatitis B Virus Studies (9 papers), HIV/AIDS drug development and treatment (3 papers), Liver Diseases and Immunity (2 papers), MicroRNA in disease regulation (2 papers), RNA modifications and cancer (2 papers) and Dermatological and COVID-19 studies (1 paper). The work is most often cited by research in Hepatology (615 citations), Epidemiology (450 citations), Infectious Diseases (140 citations), Dermatology (17 citations) and Cancer Research (26 citations). Edward Tam has collaborated with scholars based in Canada, United States and Hong Kong. Frequent co-authors include Fred Poordad, Lois Larsen, Paul Desmond, Peter Varunok, Barry Bernstein, Rui Tato Marinho, Marc Bourlière, Donald M. Jensen, Adrian M. Di Bisceglie and Stefan Zeuzem. Their work appears in journals such as Journal of Hepatology, Gastroenterology, Liver International, Journal of Clinical Microbiology and Heart Rhythm.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.